共 341 条
[1]
Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34
[2]
Miller KD(2005)Breast cancer metastasis: markers and models Nat Rev Cancer 5 591-602
[3]
Jamel A(2009)Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival Clin Med Res 7 4-13
[4]
Weigelt B(2015)HER2-family signalling mechanisms, clinical implications and targeting in breast cancer Breast Cancer Res Treat 149 5-15
[5]
Peterse JL(2003)The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy Oncologist 8 307-325
[6]
van ‘t Veer LJ(2009)The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies Exp Mol Pathol 87 1-11
[7]
Onitilo AA(2003)Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab Nature 421 756-760
[8]
Engel JM(1997)The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions FEBS Lett 410 83-86
[9]
Greenlee RT(2003)The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc Natl Acad Sci USA 100 8933-8938
[10]
Mukesh BN(2018)Understanding the biology of HER3 receptor as a therapeutic target in human cancer Acta Pharm Sin B 8 503-510